871 related articles for article (PubMed ID: 17932313)
1. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
4. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
[TBL] [Abstract][Full Text] [Related]
5. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
Nako H; Kataoka K; Koibuchi N; Dong YF; Toyama K; Yamamoto E; Yasuda O; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertens Res; 2012 Feb; 35(2):194-200. PubMed ID: 22089532
[TBL] [Abstract][Full Text] [Related]
6. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
7. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
Yamamoto E; Dong YF; Kataoka K; Yamashita T; Tokutomi Y; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Sep; 52(3):573-80. PubMed ID: 18678790
[TBL] [Abstract][Full Text] [Related]
8. Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation.
Yamamoto E; Tamamaki N; Nakamura T; Kataoka K; Tokutomi Y; Dong YF; Fukuda M; Matsuba S; Ogawa H; Kim-Mitsuyama S
Stroke; 2008 Nov; 39(11):3049-56. PubMed ID: 18688015
[TBL] [Abstract][Full Text] [Related]
9. Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II.
Widder JD; Guzik TJ; Mueller CF; Clempus RE; Schmidt HH; Dikalov SI; Griendling KK; Jones DP; Harrison DG
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):762-8. PubMed ID: 17272743
[TBL] [Abstract][Full Text] [Related]
10. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
11. Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.
Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Esaki M; Kanamori H; Li L; Ogino A; Ohno T; Kondo T; Nakagawa M; Minatoguchi S; Fujiwara T; Fujiwara H
J Card Fail; 2007 Mar; 13(2):155-62. PubMed ID: 17395057
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Yamamoto E; Yamashita T; Tanaka T; Kataoka K; Tokutomi Y; Lai ZF; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):556-63. PubMed ID: 17170375
[TBL] [Abstract][Full Text] [Related]
14. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
[TBL] [Abstract][Full Text] [Related]
15. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
Zhou MS; Schulman IH; Raij L
J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis signal-regulating kinase-1 is involved in vascular endothelial and cardiac remodeling caused by nitric oxide deficiency.
Yamashita T; Yamamoto E; Kataoka K; Nakamura T; Matsuba S; Tokutomi Y; Dong YF; Ichijo H; Ogawa H; Kim-Mitsuyama S
Hypertension; 2007 Sep; 50(3):519-24. PubMed ID: 17646574
[TBL] [Abstract][Full Text] [Related]
18. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats.
Mercier N; Labat C; Louis H; Cattan V; Benetos A; Safar ME; Lacolley P
Am J Hypertens; 2007 Mar; 20(3):319-25. PubMed ID: 17324746
[TBL] [Abstract][Full Text] [Related]
19. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling.
Su KH; Tsai JY; Kou YR; Chiang AN; Hsiao SH; Wu YL; Hou HH; Pan CC; Shyue SK; Lee TS
Cardiovasc Res; 2009 Jun; 82(3):468-75. PubMed ID: 19307231
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
